This could provide a mechanistic explanation of the retrospective postmortem human tissue-based observation that reduced cortical CHRM1 in a subset of AD patients is positively correlated to poor survival, i.e., an earlier age of death, whereas hippocampal CHRM1 is not linked to an earlier age of death. The gene discussed is CHRM1; the disease is Alzheimer disease.